Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Carlsmed (CARL) EBIAT (2024 - 2026)

Carlsmed filings provide 2 years of EBIAT readings, the most recent being -$8.6 million for Q4 2025.

  • On a quarterly basis, EBIAT fell 82.48% to -$8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$28.6 million, a N/A change, with the full-year FY2025 number at -$29.6 million, down 22.17% from a year prior.
  • EBIAT hit -$8.6 million in Q4 2025 for Carlsmed, down from -$8.5 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$4.7 million in Q4 2024 to a low of -$8.6 million in Q4 2025.